BACKGROUND: Non-syndromic hearing loss (NSHL) is the most common sensory impairment in humans. Until recently its extreme genetic heterogeneity precluded comprehensive genetic testing. Using a platform that couples targeted genomic enrichment (TGE) and massively parallel sequencing (MPS) to sequence all exons of all genes implicated in NSHL, we tested 100 persons with presumed genetic NSHL and in so doing established sequencing requirements for maximum sensitivity and defined MPS quality score metrics that obviate Sanger validation of variants. METHODS: We examined DNA from 100 sequentially collected probands with presumed genetic NSHL without exclusions due to inheritance, previous genetic testing, or type of hearing loss. We performed TGE using post-capture multiplexing in variable pool sizes followed by Illumina sequencing. We developed a local Galaxy installation on a high performance computing cluster for bioinformatics analysis. RESULTS: To obtain maximum variant sensitivity with this platform 3.2-6.3 million total mapped sequencing reads per sample were required. Quality score analysis showed that Sanger validation was not required for 95% of variants. Our overall diagnostic rate was 42%, but this varied by clinical features from 0% for persons with asymmetric hearing loss to 56% for persons with bilateral autosomal recessive NSHL. CONCLUSIONS: These findings will direct the use of TGE and MPS strategies for genetic diagnosis for NSHL. Our diagnostic rate highlights the need for further research on genetic deafness focused on novel gene identification and an improved understanding of the role of non-exonic mutations. The unsolved families we have identified provide a valuable resource to address these areas.
BACKGROUND:Non-syndromic hearing loss (NSHL) is the most common sensory impairment in humans. Until recently its extreme genetic heterogeneity precluded comprehensive genetic testing. Using a platform that couples targeted genomic enrichment (TGE) and massively parallel sequencing (MPS) to sequence all exons of all genes implicated in NSHL, we tested 100 persons with presumed genetic NSHL and in so doing established sequencing requirements for maximum sensitivity and defined MPS quality score metrics that obviate Sanger validation of variants. METHODS: We examined DNA from 100 sequentially collected probands with presumed genetic NSHL without exclusions due to inheritance, previous genetic testing, or type of hearing loss. We performed TGE using post-capture multiplexing in variable pool sizes followed by Illumina sequencing. We developed a local Galaxy installation on a high performance computing cluster for bioinformatics analysis. RESULTS: To obtain maximum variant sensitivity with this platform 3.2-6.3 million total mapped sequencing reads per sample were required. Quality score analysis showed that Sanger validation was not required for 95% of variants. Our overall diagnostic rate was 42%, but this varied by clinical features from 0% for persons with asymmetric hearing loss to 56% for persons with bilateral autosomal recessive NSHL. CONCLUSIONS: These findings will direct the use of TGE and MPS strategies for genetic diagnosis for NSHL. Our diagnostic rate highlights the need for further research on genetic deafness focused on novel gene identification and an improved understanding of the role of non-exonic mutations. The unsolved families we have identified provide a valuable resource to address these areas.
Authors: Lauren J Francey; Laura K Conlin; Hanna E Kadesch; Dinah Clark; Donna Berrodin; Yi Sun; Joe Glessner; Hakon Hakonarson; Chaim Jalas; Chaim Landau; Nancy B Spinner; Margaret Kenna; Michal Sagi; Heidi L Rehm; Ian D Krantz Journal: Am J Med Genet A Date: 2011-12-06 Impact factor: 2.802
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: A Eliot Shearer; Adam P DeLuca; Michael S Hildebrand; Kyle R Taylor; José Gurrola; Steve Scherer; Todd E Scheetz; Richard J H Smith Journal: Proc Natl Acad Sci U S A Date: 2010-11-15 Impact factor: 11.205
Authors: Anna M H Korver; Saskia Konings; Friedo W Dekker; Mieke Beers; Capi C Wever; Johan H M Frijns; Anne M Oudesluys-Murphy Journal: JAMA Date: 2010-10-20 Impact factor: 56.272
Authors: J Knijnenburg; S A J Lesnik Oberstein; K Frei; T Lucas; A C J Gijsbers; C A L Ruivenkamp; H J Tanke; K Szuhai Journal: J Med Genet Date: 2009-02-25 Impact factor: 6.318
Authors: A Eliot Shearer; Michael S Hildebrand; Harini Ravi; Swati Joshi; Angelica C Guiffre; Barbara Novak; Scott Happe; Emily M LeProust; Richard J H Smith Journal: BMC Genomics Date: 2012-11-14 Impact factor: 3.969
Authors: A Eliot Shearer; Robert W Eppsteiner; Kathy Frees; Viral Tejani; Christina M Sloan-Heggen; Carolyn Brown; Paul Abbas; Camille Dunn; Marlan R Hansen; Bruce J Gantz; Richard J H Smith Journal: Hear Res Date: 2017-02-15 Impact factor: 3.208
Authors: Mallory R Tollefson; Jacob M Litman; Guowei Qi; Claire E O'Connell; Matthew J Wipfler; Robert J Marini; Hernan V Bernabe; William T A Tollefson; Terry A Braun; Thomas L Casavant; Richard J H Smith; Michael J Schnieders Journal: Biophys J Date: 2019-07-03 Impact factor: 4.033
Authors: Sean S Ephraim; Nikhil Anand; Adam P DeLuca; Kyle R Taylor; Diana L Kolbe; Allen C Simpson; Hela Azaiez; Christina M Sloan; A Eliot Shearer; Andrea R Hallier; Thomas L Casavant; Todd E Scheetz; Richard J H Smith; Terry A Braun Journal: Bioinformatics Date: 2014-08-14 Impact factor: 6.937
Authors: A Eliot Shearer; Robert W Eppsteiner; Kevin T Booth; Sean S Ephraim; José Gurrola; Allen Simpson; E Ann Black-Ziegelbein; Swati Joshi; Harini Ravi; Angelica C Giuffre; Scott Happe; Michael S Hildebrand; Hela Azaiez; Yildirim A Bayazit; Mehmet Emin Erdal; Jose A Lopez-Escamez; Irene Gazquez; Marta L Tamayo; Nancy Y Gelvez; Greizy Lopez Leal; Chaim Jalas; Josef Ekstein; Tao Yang; Shin-ichi Usami; Kimia Kahrizi; Niloofar Bazazzadegan; Hossein Najmabadi; Todd E Scheetz; Terry A Braun; Thomas L Casavant; Emily M LeProust; Richard J H Smith Journal: Am J Hum Genet Date: 2014-09-25 Impact factor: 11.025
Authors: Naoko Sakuma; Hideaki Moteki; Hela Azaiez; Kevin T Booth; Masahiro Takahashi; Yasuhiro Arai; A Eliot Shearer; Christina M Sloan; Shin-Ya Nishio; Diana L Kolbe; Satoshi Iwasaki; Nobuhiko Oridate; Richard J H Smith; Shin-Ichi Usami Journal: Ann Otol Rhinol Laryngol Date: 2015-03-18 Impact factor: 1.547
Authors: Hideaki Moteki; Hela Azaiez; Kevin T Booth; Mitsuru Hattori; Ai Sato; Yoshihiko Sato; Mitsuo Motobayashi; Christina M Sloan; Diana L Kolbe; A Eliot Shearer; Richard J H Smith; Shin-Ichi Usami Journal: Ann Otol Rhinol Laryngol Date: 2015-03-18 Impact factor: 1.547
Authors: Fengxiao Bu; Nicolo Ghiringhelli Borsa; Michael B Jones; Erika Takanami; Carla Nishimura; Jill J Hauer; Hela Azaiez; Elizabeth A Black-Ziegelbein; Nicole C Meyer; Diana L Kolbe; Yingyue Li; Kathy Frees; Michael J Schnieders; Christie Thomas; Carla Nester; Richard J H Smith Journal: J Am Soc Nephrol Date: 2015-08-17 Impact factor: 10.121
Authors: Hideaki Moteki; Hela Azaiez; Christina M Sloan-Heggen; Kevin Booth; Shin-Ya Nishio; Keiko Wakui; Tomomi Yamaguchi; Diana L Kolbe; Yoh-Ichiro Iwasa; A Eliot Shearer; Yoshimitsu Fukushima; Richard J H Smith; Shin-Ichi Usami Journal: Ann Otol Rhinol Laryngol Date: 2016-07-28 Impact factor: 1.547